This year alone, 20,000 Australians and 2,800 New Zealanders will be diagnosed with a blood cancer such as leukaemia, lymphoma and myeloma.

Blood cancer can develop in anyone, at any age, at any time – and there are no preventative health measures available to reduce the risk of getting blood cancer.

That’s why the work of the ALLG is so important.

Our mission is to create better treatments and better lives for patients with blood cancers like leukaemia, lymphoma and myeloma.

Since 1973, ALLG researchers have conducted over 180 clinical trials that have had a significant impact on cancer care and directly enabled 14,000 patients across Australia and New Zealand to access new treatments.

The results of ALLG trials have shifted the dial, adding to global knowledge of better treatments and changing the way blood cancers are treated around the world.

ALLG believes that all patients with blood cancer deserve better and less toxic treatments that help to create better lives, better survival outcomes and potentially, a cure.

But, there’s still much more to do.

ALLG HSANZ Clinical Trials Fellowship

To change the future for blood cancer, we must accelerate research and encourage the next generation of blood cancer researchers to drive new discoveries and better treatments for patients.

The ALLG HSANZ Clinical Trials Fellowship was established in 2023 to mark the 50th anniversary of ALLG. It’s purpose is to inspire and cultivate the next generation of outstanding blood cancer researchers who will drive better treatments and outcomes for patients with leukaemia, lymphoma and myeloma.

Developing better cancer treatments and searching for a cure takes research, time, talent and funding to make it possible.

The annual Fellowship Program will provide outstanding early-career researchers a pathway to a career in clinical trial research, through engaging with ALLG trials and translational research that delivers value for patients and science.

Now in its third year, the ALLG Fellowship has a solid foundation with two exceptional early career researchers appointed as Fellows, whose innovative research is aligned and integrated with ALLG’s trial portfolio.

You can about read our Fellows here and here.

Your Support is Crucial to Success

The ALLG Clinical Trials Fellowship provides the next generation of clinical triallists with financial support, mentorship and real-world experience as they undertake a research project that enhances and integrates with existing ALLG trials that accelerate impact to people with blood cancer.

Join our visionary supporters and blood cancer research leaders by pledging your support today and help us accelerate the impact for patients with blood cancers.

Now is the time.

You can join our Impact Circle by pledging an annual donation for a minimum of 3 years or if you prefer, make a one-off donation that will help secure the future of blood cancer research.

Every donor will receive a tax-deductible receipt and recognition of their support on the ALLG website and our annual publications.

ALLG is a registered charitable organisation and does not receive any ongoing funding, relying on the generosity of individuals and organisations to achieve our mission of better treatments and better lives for patients with blood cancers.

Donate Now

You can find all the details of this important campaign in our Fellowship Project Fact Sheet. All donors will receive recognition of their donation and feature on our Accelerating Impact Donor Wall.

To find out more about the ALLG HSANZ Clinical Trials Fellowship, or to discuss your gift, please contact the ALLG Fundraising Officer:

Poorna Prakash
Fundraising Officer
E: poorna.prakash@allg.org.au
P: 03 8373 9753